Today's guest is Emmanuel Walckenaer, CEO of YSEOP. YSEOP is a natural language generation AI vendor serving life sciences and drug development. In today's episode, Emmanuel speaks about speeding up the drug development process through the lens of the life sciences industry being in extreme flux and what happens when a new normal is achieved and how companies have to scramble to keep up with it. Emmanuel also talks about the expansion of AI projects and capabilities in the enterprise. Today's episode is brought to you by YSEOP. If you're an AI vendor looking to reach a global enterprise audience, you can learn more about how we work with vendors from sponsored podcasts, articles, co-branded research, lead generation, and more at emerj.com/ad1.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related